Header Logo

Connection

Fernando Martinez to Immunosuppressive Agents

This is a "connection" page, showing publications Fernando Martinez has written about Immunosuppressive Agents.
Connection Strength

1.601
  1. Martinez FJ, McCune WJ. Cyclophosphamide for scleroderma lung disease. N Engl J Med. 2006 Jun 22; 354(25):2707-9.
    View in: PubMed
    Score: 0.222
  2. Maher TM, Assassi S, Azuma A, Cottin V, Hoffmann-Vold AM, Kreuter M, Oldham JM, Richeldi L, Valenzuela C, Wijsenbeek MS, Coeck C, Schlecker C, Voss F, Wachtlin D, Martinez FJ. Design of a phase III, double-blind, randomised, placebo-controlled trial of BI 1015550 in patients with progressive pulmonary fibrosis (FIBRONEER-ILD). BMJ Open Respir Res. 2023 09; 10(1).
    View in: PubMed
    Score: 0.183
  3. Zisman DA, Lynch JP, Toews GB, Kazerooni EA, Flint A, Martinez FJ. Cyclophosphamide in the treatment of idiopathic pulmonary fibrosis: a prospective study in patients who failed to respond to corticosteroids. Chest. 2000 Jun; 117(6):1619-26.
    View in: PubMed
    Score: 0.146
  4. Newton CA, Zhang D, Oldham JM, Kozlitina J, Ma SF, Martinez FJ, Raghu G, Noth I, Garcia CK. Telomere Length and Use of Immunosuppressive Medications in Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med. 2019 08 01; 200(3):336-347.
    View in: PubMed
    Score: 0.138
  5. Herrera C, Torres A, Garc?a-Castellano JM, Roman J, Martin C, Serrano J, Falcon M, Alvarez MA, Gomez P, Martinez F. Prevention of graft-versus-host disease in high risk patients by depletion of CD4+ and reduction of CD8+ lymphocytes in the marrow graft. Bone Marrow Transplant. 1999 Mar; 23(5):443-50.
    View in: PubMed
    Score: 0.134
  6. Tashkin DP, Roth MD, Clements PJ, Furst DE, Khanna D, Kleerup EC, Goldin J, Arriola E, Volkmann ER, Kafaja S, Silver R, Steen V, Strange C, Wise R, Wigley F, Mayes M, Riley DJ, Hussain S, Assassi S, Hsu VM, Patel B, Phillips K, Martinez F, Golden J, Connolly MK, Varga J, Dematte J, Hinchcliff ME, Fischer A, Swigris J, Meehan R, Theodore A, Simms R, Volkov S, Schraufnagel DE, Scholand MB, Frech T, Molitor JA, Highland K, Read CA, Fritzler MJ, Kim GHJ, Tseng CH, Elashoff RM. Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial. Lancet Respir Med. 2016 09; 4(9):708-719.
    View in: PubMed
    Score: 0.112
  7. Martinez F, Kamar N, Pallet N, Lang P, Durrbach A, Lebranchu Y, Adem A, Barbier S, Cassuto-Viguier E, Glowaki F, Le Meur Y, Rostaing L, Legendre C, Hermine O, Choukroun G. High dose epoetin beta in the first weeks following renal transplantation and delayed graft function: Results of the Neo-PDGF Study. Am J Transplant. 2010 Jul; 10(7):1695-700.
    View in: PubMed
    Score: 0.073
  8. Sberro-Soussan R, Zuber J, Suberbielle-Boissel C, Candon S, Martinez F, Snanoudj R, Rabant M, Pallet N, Nochy D, Anglicheau D, Leruez M, Loupy A, Thervet E, Hermine O, Legendre C. Bortezomib as the sole post-renal transplantation desensitization agent does not decrease donor-specific anti-HLA antibodies. Am J Transplant. 2010 Mar; 10(3):681-6.
    View in: PubMed
    Score: 0.071
  9. Canaud G, Zuber J, Sberro R, Royale V, Anglicheau D, Snanoudj R, Gaha K, Thervet E, Lefr?re F, Cavazzana-Calvo M, No?l LH, M?jean A, Legendre Ch, Martinez F. Intensive and prolonged treatment of focal and segmental glomerulosclerosis recurrence in adult kidney transplant recipients: a pilot study. Am J Transplant. 2009 May; 9(5):1081-6.
    View in: PubMed
    Score: 0.067
  10. Zuber J, Anglicheau D, Elie C, Bererhi L, Timsit MO, Mamzer-Bruneel MF, Ciroldi M, Martinez F, Snanoudj R, Hiesse C, Kreis H, Eustache F, Laborde K, Thervet E, Legendre C. Sirolimus may reduce fertility in male renal transplant recipients. Am J Transplant. 2008 Jul; 8(7):1471-9.
    View in: PubMed
    Score: 0.064
  11. Noth I, Martinez FJ. Recent advances in idiopathic pulmonary fibrosis. Chest. 2007 Aug; 132(2):637-50.
    View in: PubMed
    Score: 0.060
  12. Flaherty KR, Martinez FJ. Nonspecific interstitial pneumonia. Semin Respir Crit Care Med. 2006 Dec; 27(6):652-8.
    View in: PubMed
    Score: 0.057
  13. Rahaghi FF, Hsu VM, Kaner RJ, Mayes MD, Rosas IO, Saggar R, Steen VD, Strek ME, Bernstein EJ, Bhatt N, Castelino FV, Chung L, Domsic RT, Flaherty KR, Gupta N, Kahaleh B, Martinez FJ, Morrow LE, Moua T, Patel N, Shlobin OA, Southern BD, Volkmann ER, Khanna D. Expert consensus on the management of systemic sclerosis-associated interstitial lung disease. Respir Res. 2023 Jan 09; 24(1):6.
    View in: PubMed
    Score: 0.044
  14. Gay SE, Kazerooni EA, Toews GB, Lynch JP, Gross BH, Cascade PN, Spizarny DL, Flint A, Schork MA, Whyte RI, Popovich J, Hyzy R, Martinez FJ. Idiopathic pulmonary fibrosis: predicting response to therapy and survival. Am J Respir Crit Care Med. 1998 Apr; 157(4 Pt 1):1063-72.
    View in: PubMed
    Score: 0.031
  15. Whyte RI, Rossi SJ, Mulligan MS, Florn R, Baker L, Gupta S, Martinez FJ, Lynch JP. Mycophenolate mofetil for obliterative bronchiolitis syndrome after lung transplantation. Ann Thorac Surg. 1997 Oct; 64(4):945-8.
    View in: PubMed
    Score: 0.030
  16. Salisbury ML, Myers JL, Belloli EA, Kazerooni EA, Martinez FJ, Flaherty KR. Diagnosis and Treatment of Fibrotic Hypersensitivity Pneumonia. Where We Stand and Where We Need to Go. Am J Respir Crit Care Med. 2017 09 15; 196(6):690-699.
    View in: PubMed
    Score: 0.030
  17. Belloli EA, Martinez FJ, Flaherty KR. Update in Interstitial Lung Disease 2014. Am J Respir Crit Care Med. 2015 Sep 01; 192(5):538-43.
    View in: PubMed
    Score: 0.026
  18. Scemla A, Gerber S, Duquesne A, Parize P, Martinez F, Anglicheau D, Snanoudj R, Zuber M, Bougnoux ME, Legendre C, Lortholary O. Dramatic improvement of severe cryptococcosis-induced immune reconstitution syndrome with adalimumab in a renal transplant recipient. Am J Transplant. 2015 Feb; 15(2):560-4.
    View in: PubMed
    Score: 0.025
  19. Canaud G, Knebelmann B, Harris PC, Vrtovsnik F, Correas JM, Pallet N, Heyer CM, Letavernier E, Bienaim? F, Thervet E, Martinez F, Terzi F, Legendre C. Therapeutic mTOR inhibition in autosomal dominant polycystic kidney disease: What is the appropriate serum level? Am J Transplant. 2010 Jul; 10(7):1701-6.
    View in: PubMed
    Score: 0.018
  20. Legendre Ch, Kreis H, Martinez F, Snanoudj R, Mamzer MF, Sberro R, Bererhi L, Anglicheau D, Zuber J, Loupy A, Thervet E, Pallet N, Sartorius A, Bertrand D, Canaud G, No?l LH, Rabant M, Timsit MO, M?jean A. Kidney transplantation at Necker Hospital: the most recent 5-year period (2004-2009). Clin Transpl. 2010; 127-32.
    View in: PubMed
    Score: 0.018
  21. Zafrani L, Truffaut L, Kreis H, Etienne D, Rafat C, Lechaton S, Anglicheau D, Zuber J, Ciroldi M, Thervet E, Snanoudj R, Mamzer MF, Martinez F, Timsit MO, Bergougnoux L, Legendre C. Incidence, risk factors and clinical consequences of neutropenia following kidney transplantation: a retrospective study. Am J Transplant. 2009 Aug; 9(8):1816-25.
    View in: PubMed
    Score: 0.017
  22. Snanoudj R, Martinez F, Sberro Soussan R, Thervet E, Legendre C. [Screening biopsies in kidney transplantation: from subclinical acute rejection to chronic allograft lesions]. Nephrol Ther. 2008 Oct; 4 Suppl 3:S192-9.
    View in: PubMed
    Score: 0.016
  23. Anglicheau D, Loupy A, Lefaucheur C, Pessione F, L?tourneau I, C?t? I, Gaha K, No?l LH, Patey N, Droz D, Martinez F, Zuber J, Glotz D, Thervet E, Legendre C. A simple clinico-histopathological composite scoring system is highly predictive of graft outcomes in marginal donors. Am J Transplant. 2008 Nov; 8(11):2325-34.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.